New Webcast: Mapping a Path to Market—Creating a Comprehensive Drug Development Strategy

2 Comments by Emily Nichols

Research shows that for every 5,000 to 10,000 compounds entering the pipeline, only one will make it to market. As such, the responsibility falls on pharmaceutical and biotechnology companies to cut costs, shorten timelines, and increase the probability that their compound will be one of the few to succeed.

Developing a comprehensive drug development strategy is key to increasing a drug’s likelihood of making it to market. In our upcoming webcast on Wednesday, March 26, 2014 @ 11:30 am ET, you’ll learn how issues such as slow study enrollment, trial designs that do not meet regulatory expectations, or prohibitively expensive raw materials can be more easily managed or, in some cases, avoided altogether if development starts with a comprehensive strategy.

The interactive discussion will cover:

Panelists include:

Register today to reserve your spot. And be on the lookout for an accompanying eBook within the next few weeks!

Comments RSS

Mehul Govani

Looking forward to strategic planning in Reglatory field which oversees the operations from the early development stage

ERIC

Look forward to it.

Add a Comment

Comments will be moderated and may take a few minutes to appear.
Clinipace Worldwide
© 2013 CLINIPACE. All Rights Reserved. Website Privacy Statement | US-EU Safe Harbor | eLinks